• bitcoinBitcoin(BTC)$79,554.00-1.75%
  • ethereumEthereum(ETH)$2,452.16-2.50%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$721.72-0.44%
  • rippleXRP(XRP)$1.40-3.67%
  • usd-coinUSDC(USDC)$1.000.01%
  • solanaSolana(SOL)$101.85-2.11%
  • tronTRON(TRX)$0.3317690.65%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.040.54%
  • HyperliquidHyperliquid(HYPE)$84.07-3.54%
  • zcashZcash(ZEC)$1,026.848.21%
  • dogecoinDogecoin(DOGE)$0.084590-3.24%
  • RainRain(RAIN)$0.016445-4.09%
  • moneroMonero(XMR)$531.755.38%
  • USDSUSDS(USDS)$1.00-0.02%
  • chainlinkChainlink(LINK)$11.69-2.03%
  • whitebitWhiteBIT Coin(WBT)$73.12-1.08%
  • leo-tokenLEO Token(LEO)$9.22-1.05%
  • cardanoCardano(ADA)$0.210456-6.23%
  • stellarStellar(XLM)$0.179877-2.19%
  • bitcoin-cashBitcoin Cash(BCH)$247.14-3.46%
  • daiDai(DAI)$1.000.01%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • CantonCanton(CC)$0.107573-4.09%
  • USD1USD1(USD1)$1.000.01%
  • litecoinLitecoin(LTC)$52.322.31%
  • uniswapUniswap(UNI)$6.27-3.28%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.401.97%
  • hedera-hashgraphHedera(HBAR)$0.0788630.69%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • avalanche-2Avalanche(AVAX)$7.39-1.74%
  • suiSui(SUI)$0.76-1.73%
  • shiba-inuShiba Inu(SHIB)$0.000005-2.60%
  • nearNEAR Protocol(NEAR)$2.2314.03%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • tether-goldTether Gold(XAUT)$4,427.79-0.86%
  • crypto-com-chainCronos(CRO)$0.055782-3.71%
  • Circle USYCCircle USYC(USYC)$1.140.04%
  • MemeCoreMemeCore(M)$1.139.23%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • okbOKB(OKB)$109.07-0.03%
  • BittensorBittensor(TAO)$228.42-0.15%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.14-0.42%
  • aaveAave(AAVE)$130.57-2.65%
  • AsterAster(ASTER)$0.731.55%
  • pax-goldPAX Gold(PAXG)$4,435.49-0.88%
  • mantleMantle(MNT)$0.570.48%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.056528-2.51%
  • OndoOndo(ONDO)$0.3679490.86%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Scientists make ibuprofen and other common painkillers from paper industry waste

July 9, 2023
in AI & Technology
Reading Time: 2 mins read
A A
Scientists make ibuprofen and other common painkillers from paper industry waste
ShareShareShareShareShare

It’s probably fair to say that when most people conjure images of the pharmaceutical industry, it’s not often there’s an association between the production of life-saving drugs and environmental decline. But according to one 2019 study by The Conversation, drug companies produce more tonnes of carbon dioxide equivalents per million dollars than the automotive industry. “By our calculations, the pharma market is 28 percent smaller yet 13 percent more polluting than the automotive sector,” the outlet said of the state of the pharmaceutical industry in 2015. Put another way: drug companies need to reduce their carbon emissions for the health of the planet and everyone living on it.

Thankfully, a group of scientists from the University of Bath in the United Kingdom may have found a way for the industry to do exactly that. In a study published in the journal ChemSusChem, the team describes a process they created for converting β-pinene, a component found in turpentine, into pharmaceutical precursors that they then used to synthesize paracetamol and ibuprofen. Right now, most companies producing those painkillers use chemical precursors derived from crude oil. Turpentine, meanwhile, is a waste by-product the paper industry makes at a scale of more than 350,000 metric tonnes per year. The researchers say they also successfully used turpentine to synthesize 4-HAP, a precursor for beta-blockers, the asthma inhaler drug salbutamol and a range of household cleaners.

YOU MAY ALSO LIKE

How To See What’s Taking Up Space On Your Windows PC

The Tetris Company Wants Nothing To Do With The White House’s New Copycat Game

In addition to being more sustainable, the team’s “bio-refinery” process could lead to more consistent drug costs for consumers since turpentine isn’t subject to the same geopolitical pressures that can send energy and oil prices skyrocketing. However, a significant pitfall of the process in its current form is that it costs more to produce drugs with turpentine than crude oil. The team suggests consumers may be willing to pay slightly higher prices for more sustainable drugs, but let’s be honest, when someone is sick or in pain, paying more for relief is the last thing most people want to do.

Credit: Source link

ShareTweetSendSharePin

Related Posts

How To See What’s Taking Up Space On Your Windows PC
AI & Technology

How To See What’s Taking Up Space On Your Windows PC

September 4, 2026
The Tetris Company Wants Nothing To Do With The White House’s New Copycat Game
AI & Technology

The Tetris Company Wants Nothing To Do With The White House’s New Copycat Game

September 4, 2026
OpenAI Commits B to Frontline Cyber Defense, Launches MS-ISAC Pilot – Unite.AI
AI & Technology

OpenAI Commits $1B to Frontline Cyber Defense, Launches MS-ISAC Pilot – Unite.AI

September 4, 2026
Flock Cameras Are Officially Banned On State Roads In Florida
AI & Technology

Flock Cameras Are Officially Banned On State Roads In Florida

September 4, 2026
Next Post
Psychedelics Gaining Acceptance; What Does It Mean For Investors?

Psychedelics Gaining Acceptance; What Does It Mean For Investors?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Global Markets Are Selling Off… What You Need To Know

Global Markets Are Selling Off… What You Need To Know

September 3, 2026
Savannah Guthrie shares new plea to bring her mother home

Savannah Guthrie shares new plea to bring her mother home

September 4, 2026
AI agents need their own identity before they need a gateway

AI agents need their own identity before they need a gateway

August 30, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!